生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | GDC-0879 is a novel, potent, and selective inhibitor of B-Raf that inhibits pERK with an IC50 of 63 nM[1]. GDC-0879 is currently under evaluation as an antitumor agent due to its strong inhibition of the Raf/MEK/ERK signaling pathway in V600E B-Raf mutant cell lines. Specifically, GDC-0879 has low cellular pMEK1 inhibition IC50 values of 59 nM in A375 melanoma cells and 29 nM in Colo205 colorectal carcinoma cells[2]. |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
human A375 cells | Proliferation assay | Antiproliferative activity against human A375 cells expressing B-Raf V600E mutant and wild type Ras, IC50=0.5 μM | 22808911 | ||
human A375 cells | Function assay | Inhibition of b-Raf in human A375 cells assessed phosphorylation of ERK, IC50=1 μM | 22808911 | ||
human MALME3M cells | Function assay | Inhibition of ERK1/2 phosphorylation in human MALME3M cells, IC50=0.063 μM | 11717001 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.99mL 0.60mL 0.30mL |
14.95mL 2.99mL 1.50mL |
29.91mL 5.98mL 2.99mL |
参考文献 |
---|